Cargando…
Ocoxin(®) oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice
Liver metastatic disease is the main cause of death in colorectal cancer (CRC) patients. During metastatic spread of the disease an imbalance in the oxidative stress and inflammation plays a crucial role in tumor progression. In order to improve the efficacy of current therapies, new complementary t...
Autores principales: | MÁRQUEZ, JOANA, MENA, JORGE, HERNANDEZ-UNZUETA, IERA, BENEDICTO, AITOR, SANZ, EDUARDO, ARTETA, BEATRIZ, OLASO, ELVIRA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750781/ https://www.ncbi.nlm.nih.gov/pubmed/26676882 http://dx.doi.org/10.3892/or.2015.4486 |
Ejemplares similares
-
Ocoxin oral solution(®) as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liver
por: Hernandez-Unzueta, Iera, et al.
Publicado: (2017) -
Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance
por: Hernandez-Unzueta, Iera, et al.
Publicado: (2019) -
Improving the Antitumor Effect of Chemotherapy with Ocoxin as a Novel Adjuvant Agent to Treat Prostate Cancer
por: Hernandez-Unzueta, Iera, et al.
Publicado: (2023) -
Ocoxin Increases the Antitumor Effect of BRAF Inhibition and Reduces Cancer Associated Fibroblast-Mediated Chemoresistance and Protumoral Activity in Metastatic Melanoma
por: Benedicto, Aitor, et al.
Publicado: (2021) -
Ocoxin as a complement to first line treatments in cancer
por: Benedicto, Aitor, et al.
Publicado: (2021)